XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Stock-Based Compensation Expense (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense $ 2,772,202 $ 16,365 $ 6,156,539 $ 49,094
General and Administrative Expense [Member] | 2018 Equity Plan [Member]        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense 2,694,882 5,988,299
Research and Development Expense [Member] | 2018 Equity Plan [Member]        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense 21,864 13,114 57,156 39,344
Research and Development Expense [Member] | PAVmed Inc 2014 EquityPlan [Member]        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense $ 56,456 $ 3,251 $ 111,084 $ 9,750